Home/Companies/Biotech/AM Pharma

AM Pharma

Biotech·

France·Active·7yr hold

Entry

2019

Hold

7yr

Status

Active

Who owns AM Pharma?

AM Pharma is a French Biotech company, currently owned by Andera Partners since 2019 and 2 other investors.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY

Most recent investor

Andera Partners

BioDiscovery 5 · 2017 · VC

3 ownership periods · full history below

Key facts

HQFrance

SectorBiotech

Websitewww.am-pharma.com

Ownership history

3 ownership periods · co-invest detected

Active

Co-held by Ysios Capital Partners, Eurazeo and Andera Partners since 2011.

Co-invest · 3 holders · 2011 · present

Ysios Capital PartnersActive

2011 · present(15yr) · Ysios BioFund I · 2008 · Life Sciences VC

EurazeoActive

2016 · present(10yr) · Kurma Biofund III · 2017 · Healthcare

Andera PartnersActive

2019 · present(7yr) · BioDiscovery 5 · 2017 · VC

More from BioDiscovery 5

Other portfolio companies in the same fund.

to Public market (NYSE IPO ticker EVMN)

to Public market (Nasdaq IPO ticker AGMB)

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare

Active

The Carlyle GroupChina

Adagene

Active

General AtlanticChina

Advanced Cell Diagnostics

Questions

Who owns AM Pharma?

AM Pharma is currently owned by Andera Partners, Eurazeo and 1 other, through BioDiscovery 5, since 2019.

When did Andera Partners and 2 others acquire AM Pharma?

Andera Partners and 2 others acquired AM Pharma in 2019.

Who has owned AM Pharma over time?

AM Pharma has been through 3 private-equity ownership periods: Ysios Capital Partners · via Ysios BioFund I · since 2011; Eurazeo · via Kurma Biofund III · since 2016; Andera Partners · via BioDiscovery 5 · since 2019.

Look up another firm or company

Data refreshed weekly · Sourced from public filings · Report an issue